Insider · CIK 0001188919
Ted W Love
director
Files at GILD (GILEAD SCIENCES, INC.), JAZZ (Jazz Pharmaceuticals plc), RPRX (Royalty Pharma plc), GPCR (Structure Therapeutics Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -6 | $244.06 | $1,464 | 3,126 | 40 d ago |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | FTax withholding Ordinary Shares | -737 | $241.39 | $178k | 2,389 | 40 d ago |
| Jun 23, 2025 | GPCR Structure Therapeutics Inc. | AGrant or award Share Option (right to buy)derivative | +51,804 | $0.00 | $0 | 51,804 | Jun 25, 2025 |
| May 13, 2025 | RPRX Royalty Pharma plc | AGrant or award Class A Ordinary Shares | +7,614 | $0.00 | $0 | 53,848 | May 14, 2025 |
| May 7, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Common Stock | +1,516 | $0.00 | $0 | 4,338 | May 8, 2025 |
| May 7, 2025 | GILD GILEAD SCIENCES, INC. | AGrant or award Non-qualified Stock Option (Right to Buy)derivative | +6,809 | $0.00 | $0 | 6,809 | May 8, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.